The presence of microplastics in human tissues poses health risks

What's this about?

People disagree about whether tiny bits of plastic in our bodies cause major health harm.

Teams have found these bits, called microplastics, in blood, lungs, and other body parts.

What supporters say

• People take in microplastics through food, drinks, and the air, so avoiding them seems hard.
• Teams have found them in blood, lung tissue, male sex organs, and samples tied to birth.
• Lab tests show that these bits can harm cells and cause swelling, cell damage, and gene damage.
• One study linked plastic bits in clogged neck arteries with a higher later risk of heart attacks or strokes.

What critics say

• Lab tests in cells and animals cannot prove that the same harm happens in people.
• We do not yet know how much plastic most people take in or how long it stays in tissues.
• The neck artery study found a link, but it did not prove that plastic bits caused later heart or blood vessel harm.
• Many other things, such as age, diet, and illness, may affect health in people with these plastic bits.

The bottom line

Microplastics clearly enter human bodies and could harm cells.

But we do not yet have proof that real-life amounts cause major disease in people.

Microplastics have been found inside the human body, raising concern that pollution once thought to be mainly an environmental problem may also affect health. But while the evidence shows that people are exposed and that the particles could cause harm, it does not yet prove that they cause significant disease in people at known real-world exposure levels.

The case for

The most solid finding is that microplastics can move beyond the outside environment and into internal parts of the body. Researchers have reported them in human blood, lung tissue, parts of the male reproductive system and samples linked to pregnancy and birth. Their presence in blood suggests they can circulate through the body, while findings in surgically removed lung tissue suggest particles may remain there (see Figure 2). 1

Exposure is also difficult to avoid. Microplastics are found in food, drinking water and the air, and one meta-analysis reported them in commercial milk. That broad exposure makes the discovery of particles in human tissues more than an isolated laboratory curiosity. 4

Laboratory studies offer several credible explanations for how these particles might damage health. Studies in cells and animals have linked micro- and nanoplastics with inflammation, oxidative stress, damage to mitochondria, cell death, genetic damage and disrupted cell function. These effects do not establish that the same outcomes occur in people, but they show that particles lodged in tissues could plausibly contribute to injury or chronic illness. 2

The most striking human finding so far involves cardiovascular disease. In a prospective study of patients having surgery for severe narrowing of the carotid artery, some atherosclerotic plaques contained micro- and nanoplastics. Those patients later had a higher risk of cardiovascular events than patients whose plaques did not contain the particles. This moves the evidence beyond simple detection by connecting particles in diseased tissue with an important health outcome. 3

Findings in reproductive and pregnancy-related samples also deserve careful attention. Because particles have been detected in tissues relevant to fertility and early development, and because experimental studies point to inflammatory and cellular stress effects, researchers have reason to investigate these areas urgently.

The case against

The key limitation is that human studies have shown exposure and association more clearly than cause and effect. Studies detecting microplastics in blood or lung tissue were not designed to determine whether the particles caused lung disease, tissue injury or other illnesses. A systematic review found few long-term human studies and major uncertainty over what levels of exposure would be clinically meaningful. 5

Even the cardiovascular study cannot settle the question. It was observational and involved people who already had advanced carotid artery disease. Other factors could help explain the link, including underlying illness, other pollutants that travel with plastic particles, or the possibility that diseased tissue is more likely to collect them. The study signals concern, but it cannot prove that the particles themselves caused later heart attacks, strokes or related events.

There are also major challenges in measuring microplastics reliably. Results can change depending on how researchers prevent contamination, what particle sizes their tests can detect, how they identify plastic types, and how samples are processed. These differences make it hard to compare tissue-burden findings across studies or to establish a threshold at which particles become dangerous. 6

Laboratory research has similar limits. Cell and animal experiments often use particle sizes, types or concentrations that may differ sharply from the mixed, weathered particles people encounter in daily life. A harmful effect under experimental conditions therefore cannot, on its own, provide a reliable estimate of population-level risk. 7

The bottom line

The evidence supports substantial biological concern: microplastics reach internal human tissues, may persist there, and have plausible ways of causing harm. The association between particles in arterial plaques and later cardiovascular events is especially important, though it remains preliminary and cannot establish causation.

Still, the claim that their presence poses significant clinical health risks goes beyond what current evidence can demonstrate. The strongest conclusion is that microplastics in human tissue are a serious exposure and hazard signal, with a credible possibility of health harm, rather than a quantified proof of disease risk (see Figure 1).

Researchers now need standardized, long-term human studies that measure real-world exposure, track disease over time and separate plastic effects from other pollutants and pre-existing illness. Until then, confidence is high that exposure is real and potentially concerning—but not that it has been shown to cause major clinical harm at known human doses.